Inflammation in dry eye associated with rheumatoid arthritis: Cytokine and in vivo confocal microscopy study

Innate Immunity

Volumn 19, Issue 4, 2013, Pages 420-427

  Villani, Edoardo ^a,b,c   Galimberti, Daniela ^b   Papa, Nicoletta Del ^a,d   Nucci, Paolo ^a,c   Ratiglia, Roberto ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c University Eye Clinic   (Italy)

^d Gaetano Pini Orthopaedic Hospital   (Italy)

Author keywords

confocal microscopy; dry eye; inflammation; Rheumatoid arthritis; Sj gren's syndrome

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL DENSITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORNEA; DENDRITIC CELL; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; EYE INFLAMMATION; FEMALE; HUMAN; IN VIVO STUDY; LACRIMAL FLUID; MALE; OCULAR SURFACE DISEASE INDEX QUESTIONNAIRE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC THERAPY; TEAR BREAKUP TIME; TIME; TREATMENT RESPONSE; VISUAL SYSTEM PARAMETERS;

CONFOCAL MICROSCOPY; DRY EYE; INFLAMMATION; RHEUMATOID ARTHRITIS; SJÖGREN'S SYNDROME;

ADULT; ARTHRITIS, RHEUMATOID; CELL COUNT; CELLS, CULTURED; CORNEA; CYTOKINES; DRY EYE SYNDROMES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; SJOGREN'S SYNDROME; TEARS;

EID: 84878906393     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912471692     Document Type: Article

References (37)

1. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis. Eur J Radiol. 1998 ; 27: S18 - S24
2. Scutellari PN, Orzincolo C. Rheumatoid arthritis: sequences. Eur J Radiol. 1998 ; 27: S31 - S38
3. Robin J, Dugel R Immunologic disorders of the cornea and conjunctiva. New York: Churchill Livingstone ; 1988: 533-537.
4. Jabs D Ocular manifestations of the rheumatic diseases. Philadelphia: JB Lippincott ; 1992: 1-5.
5. Fujita M, Igarashi T, Kurai T, et al. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005 ; 140: 808-813
6. Lemp MA. Dry eye (keratoconjunctivitis sicca), rheumatoid arthritis, and Sjogren's syndrome. Am J Ophthalmol. 2005 ; 140: 898-899
7. Villani E, Galimberti D, Viola F, et al. Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2008 ; 49: 560-564
8. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 ; 62: 2569-2581
9. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 ; 61: 554-558
10. Prevoo MLL, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995 ; 38: 44-48
11. Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009 ; 68: 954-960
12. Barr JT, Schechtman KB, Fink BA, et al. Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection. Cornea. 1999 ; 18: 34-46
13. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf 2007; 5: 108-152.
14. Villani E, Galimberti D, Viola F, et al. The cornea in Sjögren's syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007 ; 48: 2017-2022
15. Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res. 2008 ; 86: 879-885
16. López-Cisternas J, Castillo-Díaz J, Traipe-Castro L, López-Solís RO. Use of polyurethane minisponges to collect human tear fluid. Cornea. 2006 ; 25: 312-318
17. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001 ; 42: 2283-2292
18. Li S, Sack R, Vijmasi T, et al. Antibody protein array analysis of the tear film cytokines. Optom Vis Sci. 2008 ; 85: 653-660
19. Villani E, Ceresara G, Beretta S, et al. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011 ; 52: 5215-5219
20. Villani E, Beretta S, Galimberti D, et al. In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects. Invest Ophthalmol Vis Sci. 2011 ; 52: 4829-4832
21. Villani E, Beretta S, De Capitani M, et al. In vivo confocal microscopy of meibomian glands in Sjögren's syndrome. Invest Ophthalmol Vis Sci. 2011 ; 52: 933-939
22. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry WorkShop (2007). Ocul Surf 2007; 5: 75-92.
23. Mastropasqua L, Nubile M, Lanzini M, et al. Epithelial dendritic cell distribution in normal and inflamed human cornea: in vivo confocal microscopy study. Am J Ophthalmol. 2006 ; 142: 736-744
24. Benitez del Castillo JM, Acosta MC, Wassfi MA, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007 ; 48: 173-181
25. Jones DT, Monroy D, Ji Z, et al. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994 ; 35: 3493-3504
26. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999 ; 19: 201-211
27. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007 ; 26: 431-437
28. Pflugfelder SC. Anti-inflammatory therapy of dry eye. Ocul Surf. 2003 ; 1: 31-36
29. Selvan RS, Kapadia HB, Platt JL. Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms. J Immunol. 1998 ; 161: 4388-4395
30. Okamoto T. NF-kappaB and rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 2006 ; 6: 359-372
31. Elliott MJ, Maini RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993 ; 36: 1681-1690
32. Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997 ; 337: 141-147
33. Bresnihan B, Alvaro-Gracia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998 ; 41: 2196-2204
34. Nishimoto N, Yoshizaki K, Miyasaka N, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 2004 ; 50: 1761-1769
35. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998 ; 41: 1552-1563
36. Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet. 1999 ; 354: 1932-1939
37. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003 ; 423: 356-361